Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2019-03-01

New add-on treatment to insulin for treatment of certain patients with type 1 diabetes

View source ↗

Summary

EMA announces a new add-on treatment to insulin for certain patients with type 1 diabetes, expanding therapeutic options.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications